About the Journal

The Journal of Advanced Pharmacy and Drug Development (JAPDD) is a multidisciplinary, peer-reviewed, open-access journal that serves as a dynamic platform for disseminating pioneering research and breakthroughs in the field of pharmaceutical sciences. The journal is committed to fostering academic, clinical, and industrial collaboration by publishing high-quality, evidence-based scientific content that spans drug discovery, preclinical research, formulation development, clinical trials, and translational pharmacy.

JAPDD aspires to be a catalyst in promoting innovation and knowledge exchange between researchers, clinicians, industry experts, and regulatory professionals by emphasizing scientific rigor, integrity, and ethical publishing. Our goal is to accelerate the translation of laboratory research into real-world therapeutic solutions.

The journal invites original research articles, critical reviews, short communications, and clinical or formulation-based case reports across a wide range of topics, including but not limited to:

  • Drug design and molecular modeling

  • Pharmacognosy and natural products

  • Target-based drug discovery

  • Pharmacokinetics and pharmacodynamics

  • Nanotechnology and novel drug delivery systems

  • Pharmaceutical formulation and technology

  • Clinical and hospital pharmacy practices

  • Pharmacovigilance and regulatory affairs

  • Pharmacology and toxicology

  • Pharmacoeconomics and pharmacy practice

JAPDD is published quarterly and operates under a double-blind peer review system. Articles are freely available online immediately upon acceptance and publication, ensuring global visibility, citation potential, and open scientific dialogue.

We are committed to maintaining high editorial standards, transparent publication policies, and timely review processes, providing authors with a supportive and credible venue to share their work.

Indexing Vision and Ambition

JAPDD is currently building the foundation for long-term sustainability and international recognition. We are actively working toward meeting the rigorous standards for inclusion in major abstracting and indexing services such as:

  • Directory of Open Access Journals (DOAJ)

  • Scopus

  • Web of Science (ESCI)

  • Google Scholar

  • CrossRef 

  • Index Copernicus, Publons, Pubmed and other reputable academic databases

As part of our indexing roadmap, we are committed to maintaining high editorial standards, clear ethical policies, robust peer review systems, and global accessibility. We encourage high-quality submissions from across the globe to strengthen our goal of becoming a recognized and respected journal in pharmaceutical and biomedical publishing.